WallStSmart

Abbott Laboratories (ABT)vsInteger Holdings Corp (ITGR)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Abbott Laboratories generates 2427% more annual revenue ($46.59B vs $1.84B). ABT leads profitability with a 11.7% profit margin vs 7.0%. ABT appears more attractively valued with a PEG of 1.90. ABT earns a higher WallStSmart Score of 54/100 (C-).

ABT

Buy

54

out of 100

Grade: C-

Growth: 4.0Profit: 6.0Value: 3.3Quality: 6.0
Piotroski: 4/9Altman Z: 2.71

ITGR

Hold

43

out of 100

Grade: D

Growth: 4.0Profit: 5.5Value: 4.0Quality: 6.5
Piotroski: 3/9Altman Z: 1.93
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ABTSignificantly Overvalued (-36.2%)

Margin of Safety

-36.2%

Fair Value

$74.19

Current Price

$101.29

$27.10 premium

UndervaluedFair: $74.19Overvalued
ITGRUndervalued (+7.3%)

Margin of Safety

+7.3%

Fair Value

$94.03

Current Price

$126.34

$32.31 discount

UndervaluedFair: $94.03Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ABT2 strengths · Avg: 8.5/10
Market CapQuality
$179.08B9/10

Large-cap with strong market position

Free Cash FlowQuality
$2.09B8/10

Generating 2.1B in free cash flow

ITGR1 strengths · Avg: 8.0/10
Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Areas to Watch

ABT3 concerns · Avg: 3.3/10
PEG RatioValuation
1.904/10

Expensive relative to growth rate

P/E RatioValuation
33.6x4/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
-47.5%2/10

Earnings declined 47.5%

ITGR4 concerns · Avg: 3.5/10
P/E RatioValuation
34.6x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.934/10

Grey zone — moderate risk

Profit MarginProfitability
7.0%3/10

7.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : ABT

The strongest argument for ABT centers on Market Cap, Free Cash Flow. Revenue growth of 13.0% demonstrates continued momentum.

Bull Case : ITGR

The strongest argument for ITGR centers on Price/Book.

Bear Case : ABT

The primary concerns for ABT are PEG Ratio, P/E Ratio, EPS Growth.

Bear Case : ITGR

The primary concerns for ITGR are P/E Ratio, Altman Z-Score, Profit Margin.

Key Dynamics to Monitor

ITGR carries more volatility with a beta of 0.61 — expect wider price swings.

ABT is growing revenue faster at 13.0% — sustainability is the question.

ABT generates stronger free cash flow (2.1B), providing more financial flexibility.

Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ABT scores higher overall (54/100 vs 43/100) and 13.0% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Abbott Laboratories

HEALTHCARE · MEDICAL DEVICES · USA

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.

Visit Website →

Integer Holdings Corp

HEALTHCARE · MEDICAL DEVICES · USA

Integer Holdings Corporation is an outsourced manufacturer of medical devices in the United States, Puerto Rico, Costa Rica, and internationally. The company is headquartered in Plano, Texas.

Want to dig deeper into these stocks?